(Sharecast News) - Hims & Hers Health shares fell sharply on Tuesday after the telehealth company swung to a first-quarter loss, as its shift away from cheaper compounded weight-loss drugs toward branded GLP-1 treatments hit margins and drove up restructuring costs.
The company reported a net loss of $92.1m, or 40...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE